- Report
- June 2025
- 218 Pages
Global
From €4335EUR$4,950USD£3,763GBP
- Report
- January 2026
- 196 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 180 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- February 2026
- 281 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 115 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- April 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- February 2026
- 194 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- January 2023
- 197 Pages
Global
From €4710EUR$5,566USD£3,950GBP
- Report
- September 2024
- 255 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- January 2024
- 200 Pages
Global
From €3635EUR$4,150USD£3,155GBP
- Report
- January 2023
- 232 Pages
Global
From €2190EUR$2,500USD£1,900GBP
- Report
- March 2020
- 136 Pages
Global
From €3897EUR$4,450USD£3,383GBP

The Biological Weapon market is a subset of the Biodefense industry, which focuses on the development of products and services to protect against biological threats. Biological weapons are weapons of mass destruction that use living organisms or their byproducts to cause death or disease in humans, animals, or plants. These weapons can be used to target a specific population or to cause widespread destruction.
The Biological Weapon market is composed of a variety of companies that specialize in the development of products and services to protect against biological threats. These companies include those that develop vaccines, diagnostic tests, and treatments for diseases caused by biological weapons, as well as those that develop detection systems and decontamination technologies. Additionally, there are companies that provide consulting services and training to help governments and organizations prepare for and respond to biological threats.
Some companies in the Biological Weapon market include Emergent BioSolutions, DynPort Vaccine Company, BioThrax, and BioReliance. Show Less Read more